Quest Diagnostics Inc. (NYSE: DGX) is a large market cap stock with a market cap of 12003.22. It is in the Medical Laboratories & Research industry and sector Healthcare, with a current P/E of 14.53, a forward P/E of 15.24 and EPS of 5.72. At a stock price of 83.05 (1.17%) it has a dividend yield of 1.93%.
EPS growth for the last five years have been 4.10%, more recently this last year it has grown by 28.60%. The next year growth is going to be about 6.68% and more long-term 7.82% after five years. EPS growth quarter over quarter is 68.70%. Sales growth for the past five years have been 0.60% and sales growth quarter over quarter is -1.00%.
For performance, Quest Diagnostics Inc. the past week has seen a gain of -1.28%. For the last month performance for Quest Diagnostics Inc. is -2.58%. While the last quarter is 8.25% and half year, 21.49%. Finally for the year, performance is 25.03%.
The 52-week high for Quest Diagnostics Inc., is at -4.38%, and for the 52-week low it comes to a value of 41.36%. The 20-day simple moving average is -1.16% and 11.99% for the 200-day simple moving average.
Volatility for the week is at 2.41%, and for the month it is 1.55%. Quest Diagnostics Inc., has a target price of 82.65.
In terms of debt, long term debt/equity is 0.85, and for total debt/equity Quest Diagnostics Inc. has 0.85. The gross margin is 38.70%, while operating margin is 20.70%, the profit margin is 11.00%. The current ratio is 1.4 and the quick ratio is 1.3.
Insider ownership is at 0.20%, with instituitional ownership at 96.90%. Quest Diagnostics Inc. has a payout ratio of 27.10%. With the total shares outstanding coming to 144.53. The shares float is 138.49, with the float short at 4.68%, with short ratio coming to 5.25.
In terms of returns, the return on assets see Quest Diagnostics Inc., get 8.20%, with its returns on investment at 12.30%. Return on equity is 17.90%. So will the investors see the target price of 82.65, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.